Functional antagonism: Tolerance produced by inhaled β2 agonists

Thorax

Volumn 51, Issue 10, 1996, Pages 1051-1056

  Cockcroft, D W ^a   Swystun, V A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROXATEROL; BUDESONIDE; CORTICOSTEROID; FORMOTEROL; METHACHOLINE; SALBUTAMOL; SALMETEROL; TERBUTALINE;

ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ANTAGONISM; DRUG EFFECT; DRUG TOLERANCE; HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW;

EID: 0029850935     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.10.1051     Document Type: Review

References (34)

1. Taylor DR, Sears MR, Cockcroft DW. The beta-agonist controversy. In: Cockcroft DW, Dosman JA, eds. Obstructive lung diseases Part II: Asthma, sleep, occupational exposures and AIDS. Med Clin North Am 1996;80:719-48.
2. Ahrens RC, Bonham AC, Maxwell GA, Weinberger MW. A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine. Am Rev Respir Dis 1984; 129:903-6.
3. Tattersfield AE. Tolerance to beta-agonists. Bull Eur Physiopathol Respir 1985;21:1-5s.
4. O'Connor BJ, Aikman SL, Barnes PJ. Tolerance to the nonbronchodilator effects of inhaled β-agonists in asthma. N Engl J Med 1992;327:1204-8.
5. Cockcroft DW, Hargreave FE. Airway hyperresponsiveness: definition, measurement, and clinical relevance. In: Kaliner MA, Barnes PJ, Persson CGA, eds. Asthma: its pathology and treatment. New York: Marcel Dekker, 1991: 51-72.
6. Pauwels R, Joos G, Van Der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 1988;18:317-21.
7. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
8. Finnerty JP, Wilmot C, Holgate ST. Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Am Rev Respir Dis 1989;140:593-7.
9. Anderson SD, Schoeffel RE, Finney M. Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma. Thorax 1983;38:284-91.
10. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-7.
11. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1188-203.
12. Lai CKW, Twentyman OP, Holgate ST. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in non-specific bronchial responsiveness. Am Rev Respir Dis 1989; 140:917-23.
13. Cockcroft DW, McParland CP, O'Byrne PM, Manning P, Friend JL, Rutherford BC, et al. Beclomethasone given after the early asthmatic response inhibits the late response and the increased methacholine responsiveness and cromolyn does not. J Allergy Clin Immunol 1993;91:1163-8.
14. Anderson S, Scale JP, Ferris L, Schoeffel R, Lindsay DA. An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol 1979;64:612-24.
15. Gibson GJ, Greenacre JK, Konig P, Conolly ME, Pride NB. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest 1978;72:199-206.
16. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;i:554-7.
17. 2-agonist treatment. Am Rev Respir Dis 1993;148:707-12.
18. 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995;152:1485-9.
19. Bhagat R, Swystun VA, Cockcroft DW. Salbutamol-induced increased airway responsiveness to allergen and reduced protection vs. methacholine: dose-response. J Allergy Clin Immunol 1996;97:47-52.
20. Cockcroft DW, O'Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995;96:44-9.
21. Gauvreau GM, Watson RM, Jordana M, Cockcroft D, O'Byrne PM. The effect of regular inhaled salbutamol on allergen-induced airway responses and inflammatory cells in blood and induced sputum. Am J Respir Crit Care Med 1995;151:A39.
22. Inman MD, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 1996;153:65-9.
23. 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax 1995;50:497-504.
24. Grove A, Lipworth BJ. Bronchodilator Subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995;346:201-6.
25. Verberne AAPH, Hop WCJ, Creyghton FBM, van Rooij RWG, van den Berg M, de Jongste JC, et al. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. J Allergy Clin Immunol 1996;97:938-46.
26. Ramage L, Lipworth BJ, Ingram CG, Cree JA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8.
27. Giannini D, Carletti A, Dente FL, Bacci E, Bancalari L, Di Franco A, et al. Tolerance to salmeterol in allergen induced bronchoconstriction. Am J Respir Crit Care Med 1995;151:A39.
28. Bhagat R, Kalra S, Swystun VA, Cockcroft DW. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1995;108:1235-9.
29. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996;109:953-6.
30. Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF. Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med 1995;152:1170-4.
31. 2 agonist salmeterol in mild to moderate asthmatic patients. Thorax 1993;48:1121-4.
32. Manolitsas ND, Wang J, Devalia JL, Trigg CJ, MeAulay AE, Davies RJ. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Crit Care Med 1995;151:1925-30.
33. Kraan J, Koeter GH, Van Der Mark Th W, Boorsma M, Kukler J, Sluiter HJ, et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 1988;137:44-8.
34. Kerribijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effects of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987;79:653-4.